Medical Care Technologies Inc.OTC: MDCE

Medical Care Technologies (OTC PINK: MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform

· Issued by Medical Care Technologies Inc. via ACCESS Newswire

Summary by 6ix AI

Medical Care Technologies, Inc., a technology company focused on artificial intelligence, imaging and digital wellness platforms, said on June 12, 2026 that it has begun internal beta testing (testing an early version of a product inside the company) of its MDCE Melanoma Scan Beta platform.

Key details

  • The testing is designed to evaluate platform stability, workflow performance, image management, interface responsiveness and image consistency processes.
  • The company says the platform, part of its AI-assisted imaging development, is being developed as an image organization and monitoring system intended to support managing images over time.
  • The company says the pre-screening platform is not intended to treat, cure or prevent any disease or medical condition and has not been reviewed or cleared by the U.S. Food and Drug Administration (FDA, the US drug and medical device regulator).
  • Medical Care Technologies trades on the OTC Pink market (an over-the-counter US market) under the symbol MDCE.

What’s still pending

  • The platform remains in beta-stage development.
  • The company expects to provide further updates on testing milestones, platform enhancements and future development.

6ix AI wrote this summary from the release below and checked it against the release.

Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation

MESA, AZ / ACCESS Newswire / June 12, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today announced the commencement of internal beta testing for its MDCE Melanoma Scan Beta platform.

The testing phase is designed to evaluate platform stability, workflow performance, image management functionality, interface responsiveness, and image consistency processes as the Company continues development of its AI-assisted imaging platform.

The MDCE Melanoma Scan Beta platform is being developed as an image organization and monitoring system intended to support longitudinal image management workflows. Internal testing will focus on identifying opportunities for refinement, validating core platform functions, and optimizing the overall user experience.

"Beginning structured internal testing represents an important milestone in our development process," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "Our focus is on building a stable, scalable, and well-engineered imaging platform through disciplined testing and continuous refinement."

The Company views the platform as part of its broader strategy involving AI-assisted imaging technologies, software infrastructure, and future digital wellness applications.

Medical Care Technologies emphasized that the MDCE Melanoma Scan Beta platform remains in beta-stage development. The pre-screening platform is not intended to treat, cure, or prevent any disease or medical condition and has not been reviewed or cleared by the U.S. Food and Drug Administration.

The Company expects to provide additional updates regarding testing milestones, platform enhancements, and future development initiatives as progress continues.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and consumer software innovation. The Company is actively developing technology initiatives involving AI-assisted imaging, computer vision, and scalable software platforms.

Contact Information

Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties. These statements include, but are not limited to, expectations regarding product development, testing activities, technology initiatives, future enhancements, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

View original source (ACCESS Newswire)Medical Care Technologies Inc. on 6ix

Story so far

Earlier from Medical Care Technologies

Later from Medical Care Technologies

All Medical Care Technologies news releases